Streptavidin, min. 15 U/mg, lyophilisiert, 1 mg, kunststoffverpackung.

[3-(1-Methyl-1H-pyrazol-5-yl)phenyl]boronic acid, 95.0%, 5g

8-Benzyl-8-azabicyclo[3.2.1]octan-3-amine hydrochloride, 98%, 10g

cis-3-(Benzyloxy)cyclobutyl 4-methylbenzenesulfonate, 97%, 1g

Bis(4-fluorophenyl)phosphine oxide, 97%, 25g

2-(METHYLAMINO)-6-(TRIFLUOROMETHYL)BENZONITRILE, 95.0%, 5g

N-(3-Fluoro-4-methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide, 98%, 100g

6-Methylthiazolo[4,5-b]pyridin-2-amine, 95+%, 250mg

4-Aminobenzamidindihydrochlorid, 10 g, Kunststoff

5-methyl-2-(methylsulfanyl)-3,4-dihydropyrimidin-4-one, 95%, 250mg

1-(4-Bromobenzyloxy)-2,5-difluorobenzene, 98.0%, 5g

3-(4-Chloroquinazolin-2-yl)phenyl acetate, 98%, 100mg

Methyl 6-bromo-3-chloro-2-fluorobenzoate, 95.0%, 250mg